Cell Therapy Center, Amman, Jordan - 01 Jan `23Stem-cell secretome treatment for vitiligo

Stem-cell secretome treatment for vitiligo

Official title: Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.

Status: Closed to new participants

Description:

University of Jordan enrolled about 13 participants. This experimental treatment uses cell-derived particles and signaling proteins intended to change inflammation and tissue repair. Researchers hope these signals will protect melanocytes and encourage pigment to return. Possible risks include injection or infusion reactions, allergy, inflammation, infection, and other effects that are not yet known. People ages 18 to 75 may qualify. The study is underway but is no longer accepting new participants.

Start date: January 01, 2023

Completion date: January 30, 2027

Organizer: University of Jordan

Contact: See contacts and locations in the ClinicalTrials.gov record

Link: https://clinicaltrials.gov/study/NCT06813027

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Stem-cell secretome treatment for vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions

  • What causes vitiligo?

    The exact cause is a complex puzzle, but we know the foundation: It is pre-wired in your genes. Think of your genetics as a loaded spring, just waiting for a specific "trigger" ...

  • I have a new job - should I tell colleagues about my vitiligo?

    Starting a new job can be both exciting and nerve-wracking, — especially if you’re concerned about stares or questions regarding your skin. Taking a proactive approach can help ...

  • Is it possible to stop the progression of vitiligo?

    While it's not always possible to quickly stop vitiligo progression, there are some treatments that can help slow or halt the spread of the condition in many cases: Corticostero...